Dipeptidyl peptidase IV in inflammatory CNS disease.

[1]  I. De Meester,et al.  CD26, let it cut or cut it down. , 1999, Immunology today.

[2]  U. Lendeckel,et al.  Dipeptidyl peptidase IV: a cell surface peptidase involved in regulating T cell growth (review). , 1999, International journal of molecular medicine.

[3]  R. Ransohoff,et al.  Cutting Edge Commentary: Chemokine Regulation of Experimental Autoimmune Encephalomyelitis: Temporal and Spatial Expression Patterns Govern Disease Pathogenesis , 1998, The Journal of Immunology.

[4]  D. Mason,et al.  A very high level of crossreactivity is an essential feature of the T-cell receptor. , 1998, Immunology today.

[5]  B. Fleischer,et al.  Dipeptidyl‐peptidase IV/CD26 on T cells: analysis of an alternative T‐cell activation pathway , 1998, Immunological reviews.

[6]  Chika Morimoto,et al.  The structure and function of CD26 in the T‐cell immune response , 1998, Immunological reviews.

[7]  L. Steinman,et al.  CD4+ T-cell subsets in autoimmunity. , 1997, Current opinion in immunology.

[8]  U. Lendeckel,et al.  Inhibitors of dipeptidyl peptidase IV induce secretion of transforming growth factor‐β1 in PWM‐stimulated PBMC and T cells , 1997, Immunology.

[9]  Bernhard Hemmer,et al.  Identification of High Potency Microbial and Self Ligands for a Human Autoreactive Class II–restricted T Cell Clone , 1997, The Journal of experimental medicine.

[10]  F. Bühling,et al.  Inhibitors of dipeptidyl peptidase IV (DP IV, CD26) induces secretion of transforming growth factor-β1 (TGF-β1) in stimulated mouse splenocytes and thymocytes , 1997 .

[11]  McFarland,et al.  Isolation and Characterization of Autoreactive T Cells in Experimental Autoimmune Encephalomyelitis of the Mouse , 1996, Methods.

[12]  J. Strominger,et al.  Molecular mimicry in T cell-mediated autoimmunity: Viral peptides activate human T cell clones specific for myelin basic protein , 1995, Cell.

[13]  K. Murphy,et al.  T-cell subsets in autoimmunity. , 1993, Current opinion in immunology.

[14]  H. Flad,et al.  Dipeptidyl peptidase IV (CD26) on human lymphocytes. Synthetic inhibitors of and antibodies against dipeptidyl peptidase IV suppress the proliferation of pokeweed mitogen-stimulated peripheral blood mononuclear cells, and IL-2 and IL-6 production. , 1993, Immunobiology.

[15]  R. Fujinami,et al.  Amino acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity. , 1985, Science.

[16]  H. Demuth,et al.  Dipeptidyl peptidase IV of human lymphocytes. Evidence for specific hydrolysis of glycylproline p-nitroanilide in T-lymphocytes. , 1984, The Biochemical journal.

[17]  W. Karpus.  Chemokine regulation of inflammatory-mediated nervous system diseases. , 1999, Journal of neurovirology.

[18]  R. von Baehr,et al.  The role of dipeptidyl peptidase IV in human T lymphocyte activation. Inhibitors and antibodies against dipeptidyl peptidase IV suppress lymphocyte proliferation and immunoglobulin synthesis in vitro , 1987, European journal of immunology.